Provided by Tiger Trade Technology Pte. Ltd.

PHARMARON

27.500
-0.780-2.76%
Volume:8.71M
Turnover:238.04M
Market Cap:50.46B
PE:25.05
High:28.280
Open:27.580
Low:27.020
Close:28.280
52wk High:34.860
52wk Low:14.289
Shares:1.84B
HK Float Shares:358.00M
Volume Ratio:2.02
T/O Rate:2.43%
Dividend:0.23
Dividend Rate:0.85%
EPS(LYR):1.098
ROE:10.11%
ROA:4.87%
PB:2.64
PE(LYR):25.05
PS:2.83

Loading ...

Pharmaron to Invest RMB3.00 Billion in 200-Tonne API Facility in Shaoxing

Bulletin Express
·
May 27

Ariel Investments Boosts Stake in Pharmaron with 900,700 Share Purchase

Stock News
·
May 21

Pharmaron announces RMB0.20 per share final dividend for FY2025; payment slated for 7 Aug 2026

Bulletin Express
·
May 21

Pharmaron Declares Final Dividend of RMB 0.2 per Share for Payment on August 7

Stock News
·
May 21

Pharmaron Issues Online Release of 2025 AGM Circular, Notice and Proxy Form

Bulletin Express
·
May 21

Pharmaron Releases AGM Agenda for 2025; Key Votes Cover Dividend Plan, Board Reshuffle and Capital Increase

Bulletin Express
·
May 21

Norges Bank Increases Stake in Pharmaron with 254,500 Shares at HK$18.707 Each

Stock News
·
May 19

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

Pharmaron Records Stable Share Capital and Confirms Public Float Compliance in April 2026

Bulletin Express
·
May 06

Stock Track | Pharmaron Plummets 5.10% Intraday Amid Shareholder Reduction Plans and Sector Weakness

Stock Track
·
May 05

Pharmaron Beijing Shareholders Plan to Reduce Holdings by Up to 1.5%

Stock News
·
Apr 30

PHARMARON Announces Share Pledge and Release of 11 Million Shares by Controlling Shareholder

Stock News
·
Apr 29

Pharmaron Nominates New Board Director Candidates

Stock News
·
Apr 28

PHARMARON Reports First-Quarter Net Profit of 335 Million Yuan, Up 9.75%

Stock News
·
Apr 28

Pharmaron releases 2025 Annual Report and ESG Report; online access now open, printed copies available on request

Bulletin Express
·
Apr 28

PHARMARON posts 2025 Annual and ESG reports online; shareholders may request free printed copies

Bulletin Express
·
Apr 28

Pharmaron 2025年报:营收达140.951亿元,IFRS净利同比下滑7.2%,多元化研发格局稳步拓展

Bulletin Express
·
Apr 28

Stock Track | Pharmaron Soars 6.60% Intraday as Biotech Sector Rallies on Wuxi Apptec's Strong Earnings

Stock Track
·
Apr 28

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23